Goldman Sachs’s Arbor Rapha Capital Bioholdings Corp. I Units ARCKU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-196,756
Closed -$2M 7089
2021
Q4
$2M Buy
+196,756
New +$1.99M ﹤0.01% 4253

Other funds holding ARCKU

Goldman Sachs's ARCKU Position: Q1 2022 in Review

Goldman Sachs sold out of Arbor Rapha Capital Bioholdings Corp. I Units (ARCKU) in Q1 2022, closing a stake of 196,756 shares — an estimated $2M sold.

Goldman Sachs first reported a position in ARCKU in Q4 2021 and held it in 1 quarter. The position peaked at $2M in Q4 2021. 23 funds tracked by Wall St. Rank hold ARCKU as of Q1 2022.

  • Goldman Sachs reported no remaining Arbor Rapha Capital Bioholdings Corp. I Units position as of Q1 2022 after selling out during the quarter.
  • Goldman Sachs sold 196,756 Arbor Rapha Capital Bioholdings Corp. I Units shares in Q1 2022, an estimated $2M.
  • Goldman Sachs first reported a position in Arbor Rapha Capital Bioholdings Corp. I Units in Q4 2021 and held it in 1 quarter.
  • Goldman Sachs's Arbor Rapha Capital Bioholdings Corp. I Units position peaked at $2M in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Units as of Q1 2022.

Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.